This event has already occurred.
The Power of Singing: Implications for Brain Plasticity and Recovery of Function
- When January 10, 2013, 5:30 p.m. to 6:30 p.m.
- Who Gottfried Schlaug, MD, PhD, Director, Music and Neuroimaging Laboratory, Beth Israel Deaconess Medical Center; Associate Professor of Neurology, Harvard Medical School, Boston, Massachusetts
- Where Virginia Tech Carilion Research Institute, 2 Riverside Circle, Roanoke
2 Riverside Circle, Roanoke, VA 24016
Each year tens of thousands of people in the United States suffer from aphasia, a devastating complication of stroke that causes severe communication difficulties. One of the few accepted treatments for severe non-fluent aphasic patients is melodic intonation therapy, a technique inspired by the clinical observation that some severely aphasic people can sing lyrics better than they can speak the same words. Dr. Schlaug will present research on melodic intonation therapy and discuss its implications for understanding plasticity in the human brain.
A public reception will precede this event in the VTC Cafe at 5 p.m.
Gottfried Schlaug, MD, PhD
Gottfried Schlaug, MD, PhD, is an associate professor of neurology at Harvard Medical School and chief of the Division of Cerebrovascular Disorders, director of the Music and Neuroimaging Laboratory, and director of the Stroke Recovery Laboratory at Beth Israel Deaconess Medical Center. His main research interests are centered on ways to induce and detect in-vivo brain plasticity in people recovering from stroke and in normal healthy subjects undergoing long-term, intensive training of sensorimotor skills, including playing a musical instrument. He also studies the neural correlates of unique musical skills, such as absolute pitch, and auditory-motor disorders, such as an inability to sing in tune (tone deafness) or to move to a particular beat (beat deafness). More recently, he has combined his interests in music and the brain with his clinical work to develop innovative methods of auditory-motor training aimed at enhancing speech and motor functions in stroke patients and in children with developmental disorders. Dr. Schlaug has authored or coauthored more than 200 peer-reviewed manuscripts and more than 20 book chapters. His research is supported by grants from the National Institutes of Health, the National Science Foundation, Autism Speaks, and private foundations. Dr. Schlaug earned his medical degree and a doctorate in neuroscience from the University of Cologne, Germany.